Get the most out of your supplements with a science-based approach to fat loss
Understanding how these two compounds work separately helps you make informed decisions about combining them safely

Recent Articles The Return of 503B Compounding of GLP-1 Medications Over the last two years, the surging demand for GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has created both clinical October 23, 2025 FDA Issues Import Alert on GLP-1s Following Launch of Green List On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients October 1, 2025 Thea GLP-1 Crossroads: What Pharmacies Must Know About Compliance, Coverage, and the Future of Access The surge of GLP-1 medications, from semaglutide products such as Ozempic and Wegovy to new therapies in the pipeline, has created one of September 4, 2025 Recent Webinars Navigating GLP-1 Compounding Webinar Series Stay ahead of the curve with our webinar series navigating the evolving regulatory landscape for GLP-1 compounding

Alcohol reduces inhibitions and impairs judgment, which often leads to food choices you would not make sober
Weight loss injections are medications that are given through injections that assist in weight loss